Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

Molecular Cloning: A Laboratory Manual

2001 • 133,517 citations

Molecular cloning: A laboratory manual

1990 • 85,659 citations

Molecular portraits of human breast tumours

2000 • 15,445 citations

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

2013 • 12,861 citations

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2004 • 11,185 citations

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

2001 • 10,602 citations

The Human Genome Browser at UCSC

2002 • 9,920 citations

Gene expression profiling predicts clinical outcome of breast cancer

2002 • 9,314 citations

Repeated observation of breast tumor subtypes in independent gene expression data sets

2003 • 5,356 citations

PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer

1997 • 4,753 citations

Ki67 expression in breast cancer

2016 • 4,269 citations

Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

2006 • 3,623 citations

Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

2004 • 2,644 citations

Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

2004 • 1,600 citations

Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains

2002 • 1,158 citations

A tiling resolution DNA microarray with complete coverage of the human genome

2004 • 644 citations

Selective Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 Is Generally Well-Tolerated and Has Activity in Non–Small-Cell Lung Cancer and Other Solid Tumors: Results of a Phase I Trial

2002 • 583 citations

Gene expression profiling of breast cell lines identifies potential new basal markers

2005 • 556 citations

The pleiotropic functions of the Y‐box‐binding protein, YB‐1

2003 • 480 citations

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

1997 • 426 citations

Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor Are Associated with Improved Survival in Gefitinib-Treated Chemorefractory Lung Adenocarcinomas

2005 • 338 citations

High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter

2004 • 338 citations

Prognostic Significance of Basal-Like Phenotype and Fascin Expression in Node-Negative Invasive Breast Carcinomas

2006 • 327 citations

Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.

2000 • 300 citations

Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.

1998 • 289 citations

Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling.

2003 • 284 citations

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

2005 • 282 citations

Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA Species

2005 • 254 citations

Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.

1996 • 251 citations

Implication of the Insulin-like Growth Factor-IR Pathway in the Resistance of Non–small Cell Lung Cancer Cells to Treatment with Gefitinib

2007 • 250 citations

Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer

2005 • 242 citations

Direct Involvement of the Y-box Binding Protein YB-1 in Genotoxic Stress-induced Activation of the Human Multidrug Resistance 1 Gene

1998 • 237 citations

Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib)

2005 • 228 citations

K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review

2006 • 225 citations

Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay

2006 • 204 citations

High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization

2007 • 190 citations

Association of variant ABCG2 and the pharmacokinetics of epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients

2007 • 186 citations

Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology

1988 • 160 citations

Disruption of the Y-Box Binding Protein-1 Results in Suppression of the Epidermal Growth Factor Receptor and HER-2

2006 • 154 citations

Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol‐3 kinase pathways in non‐small cell lung cancer cells

2005 • 148 citations

Early Growth Response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia.

2002 • 139 citations

Enhanced coexpression of YB‐1 and DNA topoisomerase II α genes in human colorectal carcinomas

1999 • 129 citations

Multiple Microalterations Detected at High Frequency in Oral Cancer

2005 • 126 citations

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

2003 • 123 citations

Nuclear expression of Y‐box‐binding protein‐1 correlates with P‐glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma

2003 • 121 citations

Recent advances in array comparative genomic hybridization technologies and their applications in human genetics

2005 • 119 citations

Enhanced coexpression of YB-1 and DNA topoisomerase II ? genes in human colorectal carcinomas

1999 • 113 citations

The basic and clinical implications of ABC transporters, Y‐box‐binding protein‐1 (YB‐1) and angiogenesis‐related factors in human malignancies

2003 • 105 citations

Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line

2002 • 96 citations

Comprehensive copy number profiles of breast cancer cell model genomes

2006 • 93 citations

SeeGH--a software tool for visualization of whole genome array comparative genomic hybridization data.

2004 • 93 citations

Overexpression of Collagen XVIII Is Associated with Poor Outcome and Elevated Levels of Circulating Serum Endostatin in Non–Small Cell Lung Cancer

2004 • 69 citations

Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells

2005 • 63 citations

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation

2006 • 61 citations

Use of complete coverage array comparative genomic hybridization to define copy number alterations on chromosome 3p in oral squamous cell carcinomas.

2003 • 60 citations

Insulin-Like Growth Factor-1 Inscribes a Gene Expression Profile for Angiogenic Factors and Cancer Progression in Breast Epithelial Cells

2002 • 56 citations

Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR‐overexpressing breast cancer cell lines (MCF7/ADR, MDA‐MB‐231)

2006 • 49 citations

Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.

2001 • 46 citations

The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor

2007 • 32 citations

Usefulness of predictive tests for cancer treatment.

2006 • 19 citations